Freeman Kevin Lee has filed 15 insider transactions across 1 company since February 2024.
Most recent transaction: a tax payment of 16401 shares of Health Catalyst, Inc. ($HCAT) on December 01, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 1, 2025 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | F | Common Stock | 16401 | $2.90 | 358,686.0000 | 70,730,884 | 4.37% | 0.02% |
| Sept. 2, 2025 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | F | Common Stock | 4578 | $3.36 | 375,087.0000 | 70,210,651 | 1.21% | 0.01% |
| June 2, 2025 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | F | Common Stock | 4747 | $3.63 | 379,665.0000 | 70,210,651 | 1.23% | 0.01% |
| March 3, 2025 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | F | Common Stock | 10800 | $4.58 | 384,412.0000 | 70,210,651 | 2.73% | 0.02% |
| Feb. 20, 2025 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | A | Common Stock | 18262 | $0.00 | 395,212.0000 | 70,210,651 | 4.84% | 0.03% |
| Feb. 20, 2025 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | A | Common Stock | 140000 | $0.00 | 376,950.0000 | 70,210,651 | 59.08% | 0.20% |
| Dec. 2, 2024 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | S | Common Stock | 7500 | $8.94 | 236,950.0000 | 0 | 3.07% | 0.00% |
| Dec. 1, 2024 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | F | Common Stock | 11431 | $8.97 | 244,450.0000 | 0 | 4.47% | 0.00% |
| Sept. 3, 2024 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | F | Common Stock | 2772 | $7.27 | 263,381.0000 | 0 | 1.04% | 0.00% |
| Sept. 3, 2024 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | S | Common Stock | 7500 | $7.22 | 255,881.0000 | 0 | 2.85% | 0.00% |
| June 11, 2024 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | S | Common Stock | 7500 | $6.53 | 266,153.0000 | 0 | 2.74% | 0.00% |
| June 3, 2024 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | F | Common Stock | 2951 | $6.53 | 273,653.0000 | 0 | 1.07% | 0.00% |
| March 1, 2024 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | F | Common Stock | 4540 | $8.05 | 276,604.0000 | 0 | 1.61% | 0.00% |
| Feb. 20, 2024 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | A | Common Stock | 110000 | $0.00 | 277,810.0000 | 0 | 65.55% | 0.00% |
| Feb. 20, 2024 | Health Catalyst, Inc. | $HCAT | Freeman Kevin Lee | Chief Commercial Officer | A | Common Stock | 3334 | $0.00 | 281,144.0000 | 0 | 1.20% | 0.00% |